Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pliant Therapeutics, Inc. (PLRX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,906,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Co.'s focus is on treating fibrosis by inhibiting integrin-mediated activation of TGF-ss. Co.'s main product candidate, PLN-74809, is a dual selective inhibitor of avss6 and avss1 integrins that Co. is developing for the treatment of idiopathic pulmonary fibrosis and primary sclerosing cholangitis. Co.'s second product candidate, PLN-1474, is a selective inhibitor of avss1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, which Co. has partnered with Novartis Institutes for Biomedical Research, Inc.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 60,780 243,411 2,717,120
Total Sell Value $0 $1,047,240 $4,403,797 $18,310,240
Total People Sold 0 5 5 6
Total Sell Transactions 0 5 14 45
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 133
  Page 6 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Cummings Keith Lamont Chief Financial OfficerOfficer   •       –      –    2020-06-02 3 IO $0.00 $0 D/D 0 19,300     -
   Coulie Bernard President and CEOOfficer   •       •      –    2020-06-02 3 IO $0.00 $0 I/I 0 448,920     -
   Coulie Bernard President and CEOOfficer   •       •      –    2020-06-02 3 IO $0.00 $0 D/D 0 48,840     -
   Homcy Charles J Director   –       •      –    2020-06-02 3 IO $0.00 $0 D/D 0 73,378     -
   Howes Barbara Chief Human Resource OfficerOf   •       –      –    2020-06-02 3 IO $0.00 $0 D/D 0 20,978     -
   Huh Hoyoung Director   –       •      –    2020-06-02 3 IO $0.00 $0 I/I 0 99,759     -
   Coulie Bernard President and CEO   •       •      –    2020-04-30 4 OE $2.08 $104,125 D/D 48,840 48,840     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2020-04-30 4 OE $2.08 $40,144 D/D 19,300 19,300     -

  133 Records found
  1  2  3  4  5  6    
  Page 6 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed